Rupert Bartsch

Trials

Studies that name Rupert Bartsch as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 18:48 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05865990 · HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease

  MedSIR · completed · Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult · principal investigator
• N/A
  NCT05253911 · Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.

  iOMEDICO AG · completed · HER2-positive Breast Cancer · study chair
• Ph2
  NCT04752059 · Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases

  Medical University of Vienna · completed · Breast Cancer Stage IV · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 18:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.